The role of mucoprotectants in the management of gastrointestinal disorders

scientific article

The role of mucoprotectants in the management of gastrointestinal disorders is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/17474124.2018.1378573
P698PubMed publication ID28946778

P2093author name stringCherryl Harkat
Vassilia Theodorou
Helene Eutamene
Catherine Beaufrand
P2860cites workLoperamide therapy for acute diarrhea in children: systematic review and meta-analysisQ21144674
Claudin multigene family encoding four-transmembrane domain protein components of tight junction strandsQ22008687
A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseQ22251291
Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding proteinQ24652294
Occludin: a novel integral membrane protein localizing at tight junctionsQ24657666
Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cellsQ24679401
Role of the normal gut microbiotaQ26798294
Claudins in intestines: Distribution and functional significance in health and diseasesQ27000548
Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis modelQ27321389
Human  -Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide NanonetsQ27681294
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteriaQ28594441
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitisQ29616155
Bifidobacteria can protect from enteropathogenic infection through production of acetateQ29617592
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactionsQ29617847
Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protectionQ29618129
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's diseaseQ33249005
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trialQ33466435
The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammationQ33591608
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivoQ34014510
Reciprocal interactions of the intestinal microbiota and immune system.Q34033579
Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitroQ34058314
The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestineQ34224134
The gastrointestinal mucus system in health and diseaseQ34332180
Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos).Q34565768
Acute diarrhea in adults and children: a global perspective.Q34646161
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.Q35598393
Inflammatory bowel disease: is it really just another break in the wall?Q35761217
Mechanism of cytokine modulation of epithelial tight junction barrierQ37047106
Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitisQ37086842
Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.Q37266104
Tight junctions as targets of infectious agentsQ37342208
The intestinal barrier and its regulation by neuroimmune factors.Q37727432
Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventionsQ37818374
Role of mucus layers in gut infection and inflammationQ37969288
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeuticsQ37973313
The migrating motor complex: control mechanisms and its role in health and disease.Q37997280
Intestinal barrier function in health and gastrointestinal diseaseQ38009940
Glycobiome: bacteria and mucus at the epithelial interfaceQ38114543
Cell death at the intestinal epithelial front line.Q38616012
Bismuth subsalicylate in the treatment and prevention of diarrheal diseaseQ39669478
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?Q40143265
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogensQ41029761
Structural and functional changes of the duodenum in human norovirus infectionQ42445601
Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenumQ42500499
Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout miceQ42872490
Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children.Q43223298
Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.Q45189883
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivityQ46808316
Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeabilityQ46890648
The chloride conductance of tight junctions of rat ileum can be increased by cAMP but not by carbachol.Q51542385
Gap junction hemichannels contribute to the generation of diarrhoea during infectious enteric disease.Q54397043
Mechanisms of diarrhea in collagenous colitisQ56972206
P433issue1
P304page(s)83-90
P577publication date2017-09-26
P1433published inExpert Review of Gastroenterology & HepatologyQ15733730
P1476titleThe role of mucoprotectants in the management of gastrointestinal disorders
P478volume12

Reverse relations

cites work (P2860)
Q89782405Altered Gut Microbial Fermentation and Colonization with Methanobrevibacter smithii in Renal Transplant Recipients
Q64969076Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview.
Q52679056Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview.

Search more.